Literature DB >> 109474

A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.

W Feremans, M Caudron, C Bieva.   

Abstract

A patient with lambda Bence-Jones proteinuria, Waldenström's macroglobulinaemia, and Franklin's disease (gamma HCD), but without clinical evidence of a lymphoproliferative disorder, is presented. The serum contained two distinct immunoglobulin abnormalities: a monoclonal immunoglobulin M (IgM) of lambda type, and a protein fragment which was immunologically related to immunoglobulin G (IgG) and devoid of light chain activity. This gamma HCD protein belongs to the gamma 3 subclass with a molecular weight of approximately 60,000 daltons. The urine contained a Bence-Jones lambda protein as well as the gamma HCD fragment. The two paraproteins were probably secreted by two different malignant clones. Ultrastructural study revealed pathological vacuolated plasma cells of a sort that has hitherto been principally described in association with micron HCD. The mechanism of the intracellular storage of pathological immunoglobulins is discussed in the light of the ultrastructural study.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109474      PMCID: PMC1145669          DOI: 10.1136/jcp.32.4.334

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  34 in total

1.  Immunofixation. III. Application to the study of monoclonal proteins.

Authors:  R F Ritchie; R Smith
Journal:  Clin Chem       Date:  1976-12       Impact factor: 8.327

2.  CLINICAL AND IMMUNOCHEMICAL STUDIES OF FOUR CASES OF HEAVY (H-GAMMA-2) CHAIN DISEASE.

Authors:  E F OSSERMAN; K TAKATSUKI
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

3.  HEAVY CHAIN DISEASE- A NEW DISORDER OF SERUM GAMMA-GLOBULINS : REPORT OF THE FIRST CASE.

Authors:  E C FRANKLIN; J LOWENSTEIN; B BIGELOW; M MELTZER
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

4.  MULTIPLE MYELOMA. II. STRUCTURAL FEATURES OF CELLS ASSOCIATED WITH THE PARAPROTEINEMIAS.

Authors:  D ZUCKER-FRANKLIN
Journal:  Semin Hematol       Date:  1964-04       Impact factor: 3.851

5.  Intranuclear inclusions in multiple myeloma and macroglobulinemia.

Authors:  G M BRITTIN; Y TANAKA; G BRECHER
Journal:  Blood       Date:  1963-03       Impact factor: 22.113

6.  Immunohistologic localization of gamma-1-macroglobulins, beta-2A-myeloma proteins, 6.6 S gamma-myeloma proteins and Bence Jones proteins.

Authors:  A SOLOMON; J L FAHEY; R A MALMGREN
Journal:  Blood       Date:  1963-04       Impact factor: 22.113

7.  Immunoelectrophoretic characterization of the serum and urinary proteins in plasma cell myeloma and Waldenstrom's macroglobulinemia.

Authors:  E F OSSERMAN; D LAWLOR
Journal:  Ann N Y Acad Sci       Date:  1961-08-31       Impact factor: 5.691

8.  [Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum].

Authors:  P GRABAR; C A WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1953-01

9.  Mu-chain disease.

Authors:  E C Franklin
Journal:  Arch Intern Med       Date:  1975-01

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  1 in total

1.  Immunochemical and ultrastructural study of multiple myeloma with a heavy chain protein in the serum.

Authors:  C Bartoloni; G Flamini; N Gentiloni; M A Russo; C Barone; G Gambassi; T Terranova
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.